Clincosm LogoSign in Get a demo

Diagnosis of Short Stature in Children : Study of a Cohort of Small-sized Consulting Patients

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Completed
CT.gov ID
NCT04754516
Collaborator
(none)
479
Enrollment
1
Location
1.2
Actual Duration (Months)
383.7
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Many patients consult in pediatric endocrinology because of their small size. In the majority of cases, this growth delays can be explained by a hormonal, gastroenterological cause, or a chronic disease.

Sometimes the reason for stunted growth can be constitutional bone disease, a genetic cause of short stature that is still underdiagnosed.

The investigators wish to describe and take stock of the various additional analyzes carried out and the various diagnoses made in patients who consulted in endocrino-pediatrics at the Montpellier University Hospital due to their short stature, in 2017 and 2018, in order to better screen patients with constitutional bone disease

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    479 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Diagnosis of Short Stature in Children : Study of a Cohort of Small-sized Consulting Patients in 2017 and 2018
    Actual Study Start Date :
    Jan 1, 2021
    Actual Primary Completion Date :
    Jan 31, 2021
    Actual Study Completion Date :
    Feb 8, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Study the prevalence of different diagnoses of stature delay in children [1 day]

      Study the prevalence of different diagnoses of stature delay in children

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A to 17 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion criteria:

    All the children who consulted for the first time because of their short stature, in pediatric endocrinology at the Montpellier University Hospital between January 2017 and December 2018

    Exclusion criteria:

    Patient already undergoing specialized medical follow-up due to his small size Major patient

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Uhmontpellier Montpellier France 34295

    Sponsors and Collaborators

    • University Hospital, Montpellier

    Investigators

    • Study Director: Cyril Amouroux, University Hospital, Montpellier

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Montpellier
    ClinicalTrials.gov Identifier:
    NCT04754516
    Other Study ID Numbers:
    • RECHMPL21_0065
    First Posted:
    Feb 15, 2021
    Last Update Posted:
    Feb 15, 2021
    Last Verified:
    Feb 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Montpellier
    Constitutional bone disease
    Pediatrics
    Additional relevant MeSH terms:
    Dwarfism

    Study Results

    No Results Posted as of Feb 15, 2021